N
BNTX icon

Nuveen’s BioNTech BNTX Stock Holding History

Nuveen’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-162,518
Closed -$20.2M – 3219
2023
Q1 		$20.2M Sell
162,518
-146,764
-47% -$20.2M 0.01% 1038
2022
Q4 		$46.5M Buy
309,282
+100,887
+48% +$15.5M 0.02% 565
2022
Q3 		$28.1M Buy
208,395
+55,925
+37% +$8.55M 0.01% 801
2022
Q2 		$22.7M Sell
152,470
-37,530
-20% -$5.73M 0.01% 961
2022
Q1 		$32.4M Buy
190,000
+182,634
+2,479% +$30.7M 0.01% 878
2021
Q4 		$1.9M Sell
7,366
-180,709
-96% -$49.5M ﹤0.01% 2587
2021
Q3 		$51.3M Buy
188,075
+183,376
+3,902% +$58.3M 0.02% 676
2021
Q2 		$1.05M Sell
4,699
-98
-2% -$18.5K ﹤0.01% 2987
2021
Q1 		$524K Buy
+4,797
New +$509K ﹤0.01% 3090

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's BNTX Position: Q2 2023 in Review

Nuveen sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 162,518 shares — an estimated $20.2M sold.

Nuveen first reported a position in BNTX in Q1 2021 and held it in 9 quarters. The position peaked at $51.3M in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Nuveen reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 162,518 BioNTech shares in Q2 2023, an estimated $20.2M.
  • Nuveen first reported a position in BioNTech in Q1 2021 and held it in 9 quarters.
  • Nuveen's BioNTech position peaked at $51.3M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.